Scottsdale TMS Therapy, a psychiatric clinic in Scottsdale, Arizona, has expanded its interventional psychiatry services by adding FDA-approved Spravato (esketamine) nasal spray treatments to its existing transcranial magnetic stimulation (TMS) protocols. This integration addresses a critical gap in the management of severe mood disorders, particularly for patients who have not responded to two or more standard antidepressant trials.
Conventional oral antidepressants typically require four to six weeks to produce measurable therapeutic effects, a timeline that places considerable psychological burden on individuals living with treatment-resistant depression. In contrast, esketamine therapy can reduce depressive symptoms within days by acting directly on NMDA receptors to promote neuroplasticity—the brain's ability to form new, healthier neural connections and restore circuits involved in emotional regulation.
'When standard medications fail to deliver remission, it is an indication that the underlying neural networks require a different mechanism of stimulation,' stated a spokesperson for Scottsdale TMS Therapy. 'Spravato represents a major milestone in complex mood disorder care. Because it can reduce persistent depressive symptoms and decrease suicidal ideation within days rather than weeks, it serves as an immediate lifeline that restores cognitive flexibility and prepares patients for long-term psychological stabilization.'
As a tightly regulated medication, esketamine requires structured medical administration. Scottsdale TMS Therapy operates as a fully REMS-certified clinic, satisfying all applicable federal safety and monitoring standards. Under the supervision of board-certified psychiatrists and master's-level clinicians, each outpatient session includes pre-treatment health screenings, supervised self-administration, and a mandatory two-hour post-treatment observation period during which blood pressure and vital signs are continuously monitored.
This structured medical oversight is provided within a private, comfort-focused setting designed to minimize patient stress and support emotional safety. The Scottsdale facility features Apollo TMS chairs, private treatment rooms, an on-site cafe, and an outdoor patio. To support broad access to this form of interventional care, the clinic works with major commercial payors and accepts most insurance plans, managing the full authorization process internally.
Individuals or family members seeking guidance on interventional options for severe major depressive disorder can contact the clinical admissions team at Scottsdale TMS Therapy for confidential consultations, diagnostic evaluations, and same-day insurance verification to support immediate placement.
